BEVACIZUMAB

125242 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking BEVACIZUMAB:

# Side effect Count
0 OFF LABEL USE 14881
1 DEATH 13305
2 DIARRHOEA 7454
3 DISEASE PROGRESSION 7448
4 FATIGUE 6621
5 NAUSEA 6613
6 HYPERTENSION 5933
7 VOMITING 5028
8 ANAEMIA 4504
9 PYREXIA 4134
See all common reactions for BEVACIZUMAB

BEVACIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 524 0.4209
1 GASTROINTESTINAL PERFORATION 1099 0.2641
2 COLORECTAL CANCER METASTATIC 597 0.2517
3 ENDOPHTHALMITIS 1233 0.2053
4 SUBRETINAL FLUID 224 0.2049
5 GLIOBLASTOMA 310 0.1815
6 PROTEINURIA 3147 0.1654
7 OVARIAN CANCER RECURRENT 260 0.1617
8 SMALL INTESTINAL PERFORATION 260 0.1385
9 OESOPHAGEAL VARICES HAEMORRHAGE 296 0.1362
See all enriched reactions for BEVACIZUMAB